Suture Retention Device to Facilitate Triangular Fibrocartilage Complex (TFCC) Repair Clinical Trial
Official title:
Safety and Performance of the TFCC FastFix in the Wrist
| Verified date | October 2021 |
| Source | Smith & Nephew, Inc. |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Assess safety and performance post-market of the TFCC FastFix in the wrist.
| Status | Completed |
| Enrollment | 88 |
| Est. completion date | September 29, 2021 |
| Est. primary completion date | September 29, 2021 |
| Accepts healthy volunteers | |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Patients who have undergone TFCC repair using the TFCC FastFix Device - Patients aged 18 years and older - Patients that are > 12 months post-operative. Exclusion Criteria: - Subjects who are < 12 months post-operative - Subject is entered in another investigational drug, biologic, or device study or has been treated with an investigational product within 12 months post-operative. |
| Country | Name | City | State |
|---|---|---|---|
| United States | Miami Orthopedics & Sport Medicine Institute | Miami | Florida |
| Lead Sponsor | Collaborator |
|---|---|
| Smith & Nephew, Inc. |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Rate (%) of clinical success of six months post-operative. Clinical success is defined as wrists without signs of device failure and/or re-intervention after assessment by surgeon | 6 months |